F. M. M. Pinheiro

Most-cited papers

1. Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3

   M. M. Pinheiro, F. M. M. Pinheiro, M. Torres

   2016Endocrinology, Diabetes & Metabolism Case Reports31 citations Open access

   Semantic Scholar

   Save

2. Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes.

   M. M. Pinheiro, F. M. M. Pinheiro, S. Diniz, A. Fabbri +1 more

   2021International Immunopharmacology25 citations Open access

   Semantic Scholar

   Save

3. Dipeptidyl peptidase‐4 inhibitors (DPP‐4i) combined with vitamin D3: An exploration to treat new‐onset type 1 diabetes mellitus and latent autoimmune diabetes in adults in the future

   M. M. Pinheiro, F. M. M. Pinheiro, Maria Luisa Trabachin

   2018International Immunopharmacology23 citations

   Semantic Scholar

   Save

4. How to manage intolerance to dopamine agonist in patients with prolactinoma

   M. Stumpf, F. M. M. Pinheiro, G. Silva, V. Cescato +3 more

   2023Pituitary19 citations

   Semantic Scholar

   Save

5. The first report of leukocytoclastic vasculitis induced by once-weekly subcutaneous semaglutide

   M. M. Pinheiro, Luciana Gasques de Souza, G. P. Nunes, Isis Franco Martin +6 more

   2024Current Medical Research and Opinion17 citations

   Semantic Scholar

   Save

6. Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study

   M. M. Pinheiro, F. M. M. Pinheiro, Marcelo Müller de Arruda, Geane Moron Beato +12 more

   2023Archives of Endocrinology and Metabolism12 citations Open access

   Semantic Scholar

   Save

7. Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways

   M. M. Pinheiro, F. M. M. Pinheiro, M. L. Garo, D. Pastore +4 more

   2024Metabolism and Target Organ Damage8 citations Open access

   Semantic Scholar

   Save

8. Improvement of pure sensory mononeuritis multiplex and IgG1 deficiency with sitagliptin plus Vitamin D3.

   M. M. Pinheiro, F. M. M. Pinheiro, L. Resende, S. Diniz +2 more

   2020European Review for Medical and Pharmacological Sciences7 citations

   Semantic Scholar

   Save

9. Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes

   M. M. Pinheiro, F. M. M. Pinheiro, Bruna Fioravante Di Serio, Nathalia Padilla +4 more

   2025Medical Science3 citations Open access

   Semantic Scholar

   Save

10. Type 1 diabetes prevention and treatment: Time to think outside the box

    M. M. Pinheiro, F. M. M. Pinheiro

    2023Journal of Diabetes2 citations Open access

    Semantic Scholar

    Save

11. Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013

    M. M. Pinheiro, F. M. M. Pinheiro

    2023Diabetes Care2 citations Open access

    Semantic Scholar

    Save

12. Comment on Narsale et al. Th2 cell clonal expansion at diagnosis in human type 1 diabetes. Clin Immunol. 2023 Oct 29.

    M. M. Pinheiro, F. M. M. Pinheiro, Susana Nogueira Diniz

    2023Clinical Immunology0 citations

    Semantic Scholar

    Save

13. Vitamin D3 in the Type 1 Diabetes and Latent Autoimmune Diabetes in Adults, Its Use for Prevention and Treatment

    M. M. Pinheiro, F. M. M. Pinheiro

    2019Bioactive Food as Dietary Interventions for Diabetes0 citations

    Semantic Scholar

    Save